BioSpace News Archive

Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention, today announced that Ron Rocca, CEO of Exagen, will present at the Cowen and Company 40th Annual Healthcare Conference on Monday, March 2, 2020

Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments, today reported meaningful progress in the development of its pharmaceutical grade version of Tauri-Gum™.

Boundless Bio, a company interrogating and targeting extrachromosomal DNA (ecDNA) in aggressive cancers, today announced presentations at the following upcoming conferences this month

Millendo Therapeutics, Inc. (Nasdaq: MLND), a late-stage biopharmaceutical company primarily focused on developing novel treatments for orphan endocrine diseases, announced today that Julia C. Owens, Ph.D., President and Chief Executive Officer, will present at the 9th Annual SVB Leerink Global Healthcare Conference in New York City on Wednesday, February 26, 2020 at 2:00 p.m. EST.

Livongo Health, Inc., (Nasdaq: LVGO), the leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced that executives from the Company will be presenting at the following upcoming investor conferences:

Shany, who has Served on the Board of Q Core Since 2010, Brings International Business and Operational Experience to the Infusion Device Experts

TruMed® Systems, Inc., makers of the AccuVax Vaccine Management System, releases Patient Safety Checks feature for AccuVax ES.

BETHESDA, Md. , Feb. 18, 2020 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today that the 2019 Annual Shareholder’s Meeting will be held on April 18, 2020 , at 1:00 pm in Washington, DC . The Company encou

HIMAX® PLUS OFFERS GREATER STABILITY AND A LOWER PROFILE COUPLED WITH MARKET LEADING COMPRESSION

MARLBOROUGH, Mass. , Feb 18, 2020 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in three upcoming investor conferences. On February 27, 2020 , Susie Lisa , vice president, Investor Relations, will participate in a 25-minute question-and-answer session with the host analyst at the SVB Leerink 9 th Annual Global Healthcare Conference in New Yo